ampicillin has been researched along with Diabetes Mellitus, Type 1 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, DL; Chapman, HD; Fahey, JR; Hendrix, NK; Lyons, BL; Mourino, AJ; Olekszak, HL; Racine, JJ; Ratiu, JJ; Serreze, DV | 1 |
Lavin, B; Talbot, GH; Thompson, RL | 1 |
Gibbons, GW; Grayson, ML; Karchmer, AW; McKinnon, PS; Paladino, JA | 1 |
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ | 1 |
Casado, M; Gálvez, C; Rodríguez-Maresca, M; Sánchez-Yebra, W; Torres, M; Vázquez, JA | 1 |
Borchelt, MD; Francis, SJ; Kremer, RM; Levy, RP; O'Connor, CA | 1 |
Adithan, C; Bapna, JS; Chandrasekar, S; Krishnan, M; Shashindran, CH; Sriram, G; Swaminathan, RP | 1 |
1 trial(s) available for ampicillin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Drug Costs; Drug Therapy; Drug Therapy, Combination; Foot Diseases; Hospital Costs; Hospitalization; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Penicillins; Protease Inhibitors; Sulbactam; Thienamycins | 1997 |
6 other study(ies) available for ampicillin and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Antibiotic-associated Manipulation of the Gut Microbiota and Phenotypic Restoration in NOD Mice.
Topics: Ampicillin; Animal Husbandry; Animals; Anti-Bacterial Agents; Decontamination; Diabetes Mellitus, Type 1; Disease Models, Animal; Environmental Monitoring; Feces; Gastrointestinal Microbiome; Genetic Predisposition to Disease; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Host-Pathogen Interactions; Intestines; Mice, Inbred NOD; Phenotype; Th1 Cells; Th17 Cells; Time Factors | 2017 |
Endocarditis due to vancomycin-resistant Enterococcus faecium in an immunocompromised patient: cure by administering combination therapy with quinupristin/dalfopristin and high-dose ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Recurrence; Treatment Outcome; Vancomycin Resistance; Virginiamycin | 2003 |
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection | 1997 |
[Spontaneous bacterial peritonitis due to Listeria monocytogenes].
Topics: Ampicillin; Ascites; Cefotaxime; Cholecystectomy; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Echinococcosis, Hepatic; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Listeriosis; Liver Cirrhosis; Middle Aged; Peritonitis; Postoperative Complications | 2002 |
Hemophilus influenza infection of an implantable insulin-pump pocket.
Topics: Adult; Ampicillin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Insulin Infusion Systems; Rifampin; Sulbactam | 1992 |
Differential effect of type I and type II diabetes mellitus on serum ampicillin levels.
Topics: Adult; Ampicillin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Half-Life; Humans; Injections, Intravenous; Male | 1989 |